Schedule 13D ownership disclosure

Evommune Inc

Common Stock, $0.0001 par value per share · CUSIP: 30054Y107

Event date: 2025-11-07

Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.

Filing-level shares
Unavailable
Percent of class
Unavailable
  • LSP 7 Cooperatieve U.A.Reported CIK 0001876264

    Shares: 4,929,633 · Class: 15.7%

  • LSP 7 Management B.V.

    Shares: 4,929,633 · Class: 15.7%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001193125-25-283141
Form type
SCHEDULE 13D
Filer
Evommune, Inc.
CIK
CIK 2044725
Filed
Nov 14, 2025
Reporting period
Nov 07, 2025
Description
Schedule 13D beneficial ownership

Explore SEC Filings Hub